1. Plasma Trough Concentrations of Antihypertensive Drugs for the Assessment of Treatment Adherence
   Eline H. Groenland et al, 2021, Hypertension CrossRef
2. Drug toxicity and forensic pharmacokinetics
   Pinaki Sengupta et al, 2022, Pharmacokinetics and Toxicokinetic Considerations CrossRef
3. The potential implication of SCN1A and CYP3A5 genetic variants on antiepileptic drug resistance among Egyptian epileptic children
   Wafaa Moustafa M. Abo El Fotoh et al, 2016, Seizure CrossRef
4. Construction and verification of CYP3A5 gene polymorphisms using a Saccharomyces cerevisiae expression system to predict drug metabolism
   Yao Lu et al, 2017, Molecular Medicine Reports CrossRef
5. The clinical impact of anti-hypertensive treatment drug-gene pairs in the asian population: a systematic review of publications in the past decade
   Sarah Wai Yee Tang et al, 2022, Journal of Human Hypertension CrossRef
6. Genetic Variation in CYP2D6 and SLC22A1 Affects Amlodipine Pharmacokinetics and Safety
   Paula Soria-Chacartegui et al, 2023, Pharmaceutics CrossRef
7. Allele-specific polymerase chain reaction for the detection of single nucleotide polymorphism in amlodipine-induced gingival enlargement
   N. Kala et al, 2018, Journal of Clinical Pharmacy and Therapeutics CrossRef
8. Physiologically Based Pharmacokinetic Modeling of Fimasartan, Amlodipine, and Hydrochlorothiazide for the Investigation of Drug–Drug Interaction Potentials
   Su-jin Rhee et al, 2018, Pharmaceutical Research CrossRef
9. Pharmacogenomics of amlodipine and hydrochlorothiazide therapy and the quest for improved control of hypertension: a mini review
   Rabia Johnson et al, 2019, Heart Failure Reviews CrossRef
10. Pharmacogenetic association of the NR1H3 promoter variant with antihypertensive response among patients with hypertension: A longitudinal study
    Yu Chen et al, 2023, Frontiers in Pharmacology CrossRef
11. Hypertension in African Populations: Review and Computational Insights
    Sihle E. Mabhida et al, 2021, Genes CrossRef